Comparing the Efficacy and Safety of Two Analgesic Regimens After Cardiac Surgery: Slow Release and Breakthrough Tapentadol versus Slow Release and Breakthrough Oxycodone
Journal of Cardiothoracic and Vascular Anesthesia · 2025
DOI: 10.1053/j.jvca.2025.05.032 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Journal of Cardiothoracic and Vascular Anesthesia, 2025. Verfasst von Robert Wojnar und 3 weiteren Autor:innen. Beteiligte Einrichtung: Cabrini Pharmacy, Cabrini Health, Melbourne, VIC, Australia. Electronic address: rwojnar@cabrini.com.au. Hauptthemen laut MEDLINE: Oxycodone, Cardiac Surgical Procedures, Postoperative Pain, Analgesics, Opioid. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 30 Literaturangaben.
Abstract (Originalsprache)
OBJECTIVES: To compare the analgesic outcome of two oral opioid regimens after cardiac surgery. DESIGN: A retrospective cohort study. SETTING: A single tertiary-care facility. PARTICIPANTS: Opioid-naïve adult patients following cardiac surgery via a sternotomy. INTERVENTIONS: Patients received 1 of 2 regimens after extubation, an oxycodone protocol or a tapentadol protocol. Each protocol contained at least 3 doses of a slow-release oral formulation with immediate-release doses of the same opioid for breakthrough analgesia. Both protocols included regular paracetamol. Other analgesia for refractory pain was as directed by the physician. MEASUREMENTS AND MAIN RESULTS: Daily worst pain score was documented at rest and on movement in patients prescribed the oxycodone protocol and those prescribed the tapentadol protocol for 7 days after extubation. There was no significant difference between the tapentadol and oxycodone groups in worst pain at rest (odds ratio [OR] 1.77; 95% confidence interval [CI], 0.56-5.65; p = 0.334) or worst pain on movement (OR, 3.23; 95% CI, 0.85-12.32; p = 0.086) over the first 7 days post extubation. Despite a rapid de-escalation of opioids, the documented worst pain at rest and on movement by day 7, decreased by 96% in the tapentadol group and by 94% in the oxycodone group. CONCLUSIONS: This retrospective cohort study demonstrates that tapentadol compared to oxycodone is an effective alternative for managing pain after cardiac surgery performed via sternotomy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Cabrini Pharmacy, Cabrini Health, Melbourne, VIC, Australia. Electronic address: rwojnar@cabrini.com.au.
- Cabrini Pharmacy, Cabrini Health, Melbourne, VIC, Australia.
- Cabrini Research, Cabrini Health, Melbourne, VIC, Australia; School of Public Health and Preventive Medicine, Monash University, Melbourne, VIC, Australia; School of Clinical Sciences, Monash University, Melbourne, VIC,…
- Intensive Care Unit, Cabrini Health, Melbourne, VIC, Australia; Monash University Faculty of Medicine, Nursing and Health Sciences.
Zitieren
APA
Wojnar, R., Jeong, S. H., Asghari-Jafarabadi, M., & Philpot, S. (2025). Comparing the Efficacy and Safety of Two Analgesic Regimens After Cardiac Surgery: Slow Release and Breakthrough Tapentadol versus Slow Release and Breakthrough Oxycodone. Journal of Cardiothoracic and Vascular Anesthesia. https://doi.org/10.1053/j.jvca.2025.05.032
Vancouver
Wojnar R, Jeong SH, Asghari-Jafarabadi M, Philpot S. Comparing the Efficacy and Safety of Two Analgesic Regimens After Cardiac Surgery: Slow Release and Breakthrough Tapentadol versus Slow Release and Breakthrough Oxycodone. Journal of Cardiothoracic and Vascular Anesthesia. 2025. doi:10.1053/j.jvca.2025.05.032
BibTeX
@article{Wojnar2025,
author = {Wojnar, Robert and Jeong, Seo Hyeon and Asghari-Jafarabadi, Mohammad and Philpot, Steve},
title = {Comparing the Efficacy and Safety of Two Analgesic Regimens After Cardiac Surgery: Slow Release and Breakthrough Tapentadol versus Slow Release and Breakthrough Oxycodone},
journal = {Journal of Cardiothoracic and Vascular Anesthesia},
year = {2025},
doi = {10.1053/j.jvca.2025.05.032}
}
EUVIMED